BioInfra Co Ltd (199730)

Currency in KRW
775
-20(-2.52%)
Closed·
High dividend Yield
199730 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7501,010
52 wk Range
6825,420
Key Statistics
Bid/Ask
775.00 / 780.00
Prev. Close
775
Open
795
Day's Range
750-1,010
52 wk Range
682-5,420
Volume
268.82K
Average Volume (3m)
124.72K
1-Year Change
-84.7441%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
199730 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
May have trouble making interest payments on debt

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Jul 30, 2026
EPS / Forecast
0.30 / --
Revenue / Forecast
8.5B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -1,703.85%
Dividend Yield
37.74%
Industry Median 1.11%
Annualized payout
300.00
Paid annually
5-Years Growth
-
Growth Streak

199730 Income Statement

Compare 199730 to Peers and Sector

Metrics to compare
199730
Peers
Sector
Relationship
P/E Ratio
−0.5x1.8x−0.4x
PEG Ratio
0.010.020.00
Price/Book
0.3x1.1x2.6x
Price / LTM Sales
0.1x2.3x3.1x
Upside (Analyst Target)
-106.3%55.6%
Fair Value Upside
Unlock17.2%7.8%Unlock

BioInfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. The company provides clinical, which undertakes clinical trials for new drug development approval (Phase I-III) and late clinical trials; immunoassay, which performs pharmacokinetic, toxicokinetic, and biomarker analysis of polymer biopharmaceuticals; and testing and inspection, which provides finished drug product quality inspection, comparative dissolution testing, and long-term stability testing. It also specializes in bioequivalence testing of generic drugs, phase 1 clinical trials for new and improved drugs; and sample analysis services for new drug substances. The company was founded in 2007 and is based in Yongin-si, South Korea.

People Also Watch

47,900
007340
-3.43%
46,600
009420
+1.41%
184,600
005830
-0.70%
60,300
006120
+4.87%
36,800
007690
-1.87%

FAQ

What Is the BioInfra (199730) Stock Price Today?

The BioInfra stock price today is 775 KRW.

What Stock Exchange Does BioInfra Trade On?

BioInfra is listed and trades on the KOSDAQ.

What Is the Stock Symbol for BioInfra?

The stock symbol for BioInfra is "199730."

Does BioInfra Pay Dividends? What’s The Current Dividend Yield?

The BioInfra dividend yield is 37.74%.

What Is the BioInfra Market Cap?

As of today, BioInfra market cap is 3.77B KRW.

What Is BioInfra's Earnings Per Share (TTM)?

The BioInfra EPS (TTM) is -1,704.

From a Technical Analysis Perspective, Is 199730 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BioInfra Stock Split?

BioInfra has split 0 times.

What is the current trading status of BioInfra (199730)?

As of Sep 24, 2026, BioInfra (199730) is trading at a price of 775 KRW, with a previous close of 775 KRW. The stock has fluctuated within a day range of 750 KRW to 1,010 KRW, while its 52-week range spans from 682 KRW to 5,420 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.